Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-11-10

Clinical Trial Update: 0.15 mg Spinal Morphine vs. no Treatment for Morphine Requirement After VATs. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether 0.15 mg intrathecal morphine reduces morphine requirements after video-assisted thoracoscopic surgery compared …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinal morphine (intrathecal morphine) (Morphine sulfate)

Snippet

Sponsor: Mahidol University | Conditions: Postoperative Pain | Phase 4 | Status: UNKNOWN